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Abstract 
Cystathionine beta synthase deficiency induces hyperhomocysteinemia which 
is considered as a risk factor for vascular diseases. Studies underlined the 
importance of altered cellular redox reactions in hyperhomocysteinemia-induced 
vascular pathologies. Nevertheless, hyperhomocysteinemia also induces hepatic 
dysfunction which may accelerate the development of vascular pathologies by 
modifying cholesterol homeostasis. The aim of the present study was to analyze the 
modifications of redox state in the liver of heterozygous cystathionine beta synthase-
deficient mice, a murine model of hyperhomocysteinemia. In this purpose, we 
quantified levels of reactive oxygen and nitrogen species and we assayed activities 
of main antioxidant enzymes. We found that cystathionine beta synthase deficiency 
induced NADPH oxidase activation. However, there was no accumulation of reactive 
oxygen (superoxide anion, hydrogen peroxide) and nitrogen (nitrite, peroxynitrite) 
species. On the contrary, hepatic hydrogen peroxide level was decreased 
independently of an activation of glutathione-dependent mechanisms. In fact, 
cystathionine beta synthase deficiency had no effect on glutathione peroxidase, 
glutathione reductase and glutathione S-transferase activities. However, we found a 
50% increase in hepatic catalase activity without any variation of expression. These 
findings demonstrate that cystathionine beta synthase deficiency initiates redox 
disequilibrium in the liver. However, the activation of catalase attenuates oxidative 
impairments. 
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Introduction 
Homocysteine (Hcy) is a thiol-containing amino acid at the crossroad of the 
methionine metabolism (Fig. 1). Dietary methionine is adenosylated by methionine 
adenosyl transferase to form S-adenosyl methionine, the universal methyl donor. 
Once formed via the demethylation pathway, Hcy may undergo remethylation to form 
methionine via folate- or betaine-dependent mechanisms. Otherwise, Hcy may enter 
the transsulfuration pathway leading to the formation of cysteine and then glutathione 
(GSH), the major cellular antioxidant. GSH is used by glutathione peroxidase (GPx) 
to detoxify hydrogen peroxide (H2O2) and oxidized glutathione (GSSG) is 
subsequently regenerated to GSH by glutathione reductase (GRed). GSH also 
serves as a substrate for glutathione S-transferase (GST) in the detoxification of 
xenobiotics or endogenous compounds such as lipid peroxides. 
Abnormally high plasma Hcy levels are characteristic of 
hyperhomocysteinemia, a metabolic disease which can be due to altered genetic or 
nutritional factors involved in Hcy metabolism [1]. Three different types of 
hyperhomocysteinemia were identified depending on Hcy concentration: moderate 
(15-30 µM), intermediate (30-100 µM) and severe (> 100 µM) [2]. Necropsies of 
severe hyperhomocysteinemic patients notably revealed atherosclerosis, thrombosis 
and hepatic steatosis [3,4]. Moreover, even a moderate elevation of total Hcy level is 
recognized as an independent vascular risk factor for atherothrombosis in the 
coronary, cerebrovascular and peripheral arterial circulation [5-8]. 
Several studies reported impaired endothelial functionality and antithrombotic 
mechanisms [9]. In vivo studies supported by in vitro results imputed notably the 
impairment of endothelial vasomotor function to Hcy-induced reduced NO 
bioavailability [10,11]. Even if vascular toxicity of Hcy is indisputable, the hepatic 
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dysfunction might play a key role in the development of vascular diseases. In this 
sense, Hcy metabolism is mainly hepatic [12] and liver damage promotes 
hyperhomocysteinemia through cystathionine beta synthase (CBS), betaine 
homocysteine methyl transferase and methionine synthase downregulation [13]. 
Furthermore, several vascular atherogenic factors arise from hepatic dysfunction 
induced by hyperhomocysteinemia [14-18]. In vitro studies have shown that cellular 
damage induced by Hcy were linked to oxidative stress [19, 20] and GPx-1 
overexpression rescued Hcy-induced endothelial dysfunction in vivo [21]. Hcy is 
thought to induce reactive oxygen species (ROS) accumulation either by direct ROS 
generation via auto-oxidation [22] or by disturbing the balance between prooxidant 
and antioxidant activities. Such a desequilibrium between ROS producing and 
detoxifying enzymatic activities arises primarily from an increased production of 
superoxide anion (O2˙-), the univalent reduction of dioxygen, by mitochondrial 
respiratory complexes or various oxidases such as nicotinamide adenine dinucleotide 
phosphate (NADPH) oxidase and xanthine oxidase. O2˙- can react with nitric oxide 
(NO) to form peroxynitrite (ONOO-), a DNA and protein damaging agent. Thus an 
increase in O2˙- production can decrease NO bioavailability. Therefore O2˙- is rapidly 
dismutated into H2O2 by superoxide dismutase (SOD). However, H2O2 itself is a 
cytotoxic oxygen radical and leads through the Fenton's reaction to the formation of 
the highly reactive hydroxyl radical (HO˙). Thus H2O2 is degraded to H2O and O2 by 
catalase (CAT) and GPx. 
Experimental hyperhomocysteinemia can be obtained by dietary interventions 
such as vitamin B6, B12,and folate deficiency or methionine supplementation, or by 
genetic approaches such as CBS [23], methylene tetrahydrofolate reductase [24] and 
methionine synthase [25] deficiency. Some of these hyperhomocysteinemic models 
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have notably been used to elicit Hcy influence on main hepatic antioxidant activities 
[26-31]. However, the influence of CBS deficiency on hepatic redox state has never 
been extensively studied. Heterozygous CBS-deficient mice show hepatic gene 
expression modulation of several cytochromes, indicating perturbation of the hepatic 
redox potential [32]. Therefore, we characterized the hepatic redox state in CBS-
deficient mice by quantification of ROS, reactive nitrogen species (RNS) and 
activities of the main enzymes involved in redox homeostasis.
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Materials and Methods 
Chemicals and antibodies 
Unless mentioned otherwise all chemicals and antibodies were obtained from 
Sigma (Sigma-Aldrich, Saint Quentin Fallavier, France). 
 
Mice 
Animal care was conducted in accordance with internal guidelines of the 
French Ministère de l'Agriculture for animal handling. Mice heterozygous for targeted 
disruption of the Cbs gene (Cbs +/-) [23] were generously donated by Dr. N. Maeda 
(Department of Pathology, University of North Carolina, Chapel Hill, NC, USA). Cbs 
+/- mice, on a C57BL/6 background, and their wild-type C57BL/6 littermates (Cbs 
+/+) were used. Cbs +/- mice were produced by mating male Cbs +/- mice with 
female Cbs +/+ mice. Tail biopsies were performed on mice at 4 weeks of age and 
polymerase chain reaction was used for genotyping as previously described [23]. 
Mice were fed a standard laboratory diet (A03, Safe, Augy, France) given ad libitum. 
This diet has an approximative protein content of 21%, a methionine content of 4.8 
g.kg-1, a folic acid content of 0.9 mg.kg-1 and a vitamin B6 and B12 content of 
respectively 3.5 and 0.04 mg.kg-1. 
 
Preparation of samples and plasma total Hcy assay 
At time of sacrifice, blood samples were collected into tubes containing 1/10 
volume of 3.8% sodium citrate and placed on ice immediately. Plasma was isolated 
by centrifugation at 2500 g for 15 min at 4°C. Plasma total Hcy was assayed by using 
the fluorimetric high-performance liquid chromatography method described by Fortin 
and Genest [33]. Livers were harvested, snap-frozen and stored at -80°C until use. 
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100 mg of liver were homogenized in 500 µL Dulbecco's phosphate-buffered saline 
(Invitrogen, Cergy, France) containing proteases inhibitors. Homogenates were 
centrifuged at 13000g for 15 min at 4°C. Supernatants were then assayed for protein 
concentrations by the Bradford assay. 
 
RNA extraction and determination of mRNA levels 
RNA were prepared from liver with the NucleoSpin RNA II kit (Macherey 
Nagel, Hoerdt, France). Quantity and purity of the RNA were assessed by measuring 
absorbance at 260 and 280 nm. Reverse transcription was carried out on 1 µg RNA 
as described by the manufacturer (Applied Biosystems, Courtaboeuf, France). 
Catalase and heme oxygenase 1 (HO-1) mRNA levels were analyzed by real-time 
quantitative reverse transcription-polymerase chain reaction as previously described 
[18] using the Light Cycler FastStart DNA Master SYBR Green I Kit (Roche 
Diagnostics, Meylan, France). Primers (Eurogentec SA, Seraing, Belgium; Table 1) 
were designed with the Primer3 software [34] to yield a single amplicon based on 
dissociation curves. Each reaction was performed in duplicate. The mouse 
superoxide dismutase-1 mRNA was used as an endogenous control [32]. ΔΔCp 
analysis of results allows to assess the ratio of the target mRNA versus control 
mRNA [35]. 
 
Western Blot analysis 
60 µg of total proteins were subjected to SDS electrophoresis on 12% 
acrylamide gels under reducing conditions and transferred to Hybond-C Extra 
membrane (GE Healthcare Europe GmbH, Saclay, France). After transfer, 
membranes were blocked in 10% nonfat dry milk in Tris-saline buffer (1.5 mM Tris, 5 
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mM NaCl, 0.1% Tween 20) and probed with anti-heme oxygenase 1 (HO-1) antibody 
(Calbiochem, San Diego, USA). Horseradish peroxidase-conjugated secondary 
antibody and Western Blotting Luminol Reagent (Santa Cruz Biotechnology, 
Heidelberg, Germany) were used to detect specific proteins. β-actin was used as 
internal control. 
 
Measurement of NADPH oxidase activity 
NADPH oxidase activity was measured by monitoring the oxidation rate of 
cytochrome c as described by Iwai et al. [36] with 20 µg of total proteins. NADPH 
oxidase activity was quantified from the absorbances at 540, 550 and 560 nm as 
previously described [37]. 
 
Determination of superoxide anion content 
O2˙- levels were determined on 300 µg of total proteins after hemoglobin 
precipitation by monitoring the oxidation of dihydroethidium into ethidium as 
described by Woo et al. [26]. 
 
Measurement of SOD activity 
SOD activity was measured with 20 µg of total proteins by using the 
Superoxide Dismutase Kit (R&D Systems Europe, Lille, France) following supplier's 
instructions. Measurement of enzyme activity is based on the competition of SOD 
and nitroblue-tetrazolium for O2˙-. 
 
Determination of hydrogen peroxide content 
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H2O2 was quantified on 100 µg of proteins, after hemoglobin precipitation, with 
the Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit (Invitrogen, Cergy, 
France) as recommanded by supplier's instructions. Measurement of H2O2 level is 
based on the production of resofurin by H2O2 and Amplex Red reagent in the 
presence of peroxidase. 
 
Determination of nitrites and nitrates contents 
Nitrites and nitrates levels were determined by Marzinzig et al. modified Griess 
reaction [38]. 8 mg of total protein were deproteinized by acetonitrile-chloroform 
protein precipitation [39]. To reduce nitrates into nitrites 400 µL of deproteinized 
sample were incubated in the dark for 1 hour at 37°C with 20 µL FAD 200 µM, 20 µL 
NADPH 6 mM and 10 µL nitrate reductase 5 U/mL. Then excess NADPH was 
oxidized with 20 mM sodium pyruvate and 0.5 U L-lactate dehydrogenase in a final 
volume of 500 µL. Total nitrites levels (representing nitrites and nitrates) were 
spectrophotometrically determined at 550 nm after 5 minutes incubation with not 
premixed 250 µL ice-cold dapsone (4,4'-diamino-diphenylsulfone; 14 mM in 2 N HCl) 
and 250 µL 4 mM N-(1-naphtyl)-ethylendiamine. 
 
Determination of peroxynitrite content 
ONOO- levels were measured by assaying ONOO--mediated nitration of 
phenol with 200 µg of total proteins as described by VanUffelen et al. [40]. 
 
Measurement of catalase activity 
CAT activity was measured on liver extract corresponding to 25 µg of total 
proteins in 1.5 mL of 50 mM Tris buffer pH 7.8, containing 2 mM MgCl2 and 2 mM 
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CaCl2.The maximum CAT activity was determined with a sensitive Clark electrode 
measuring dioxygen produced by the dismutation of H2O2. 2-8 µL H2O2 (100 mM) 
were progressively injected, in order to obtain the maximum production rate of 
dioxygen. 
 
Measurement of glutathione peroxidase activity 
GPx activity was measured by the modified Paglia and Valentine method [41] 
described by Carmagnol et al. [42]. Hemoglobin was first converted to 
cyanmethemoglobin to avoid interference. Total proteins were incubated at 30°C in 1 
mL of 0.1 M potassium phosphate buffer with 1 mM glutathione, 1mM tert-butyl 
hydroperoxide, 1.4 units of GRed (Type III), 1.43 mM NADPH and 1.5 mM KCN. 
GSSG produced by GPx and hydroperoxide was reduced by NADPH and GRed. 
Then NADPH oxidation was followed spectrophotometrically at 340 nm. 
 
Measurement of glutathione reductase activity 
GRed activity was measured by spectrophotometrically monitoring NADPH 
oxidation at 340 nm as described by Carlberg and Mannervik [43]. Total proteins 
were incubated at 30 °C in 1 mL of 0.1 M potassium phosphate buffer with 2 mM 
NADPH and 20 mM glutathione disulfide. 
 
Measurement of glutathione S-transferase activity 
GST activity was assayed by the method described by Habig et al. [44]. S-
conjugate formation was followed at 25°C, pH 6.5 in a 0.1 M phosphate potassium 
buffer with 1mM GSH and 1 mM 1-chloro-2,4-dinitrobenzene by monitoring changes 
in absorbance at 340 nm. 
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Statistical analysis 
Results are expressed as mean ± SEM. Statistical analysis was done with 
Mann-Whitney-Wilcoxon’s test using R software (http://www.R-project.org). Data 
were considered significant when p ≤ 0.05. 
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Results 
Plasma Hcy levels in CBS-deficient mice 
In order to characterize the effects of CBS deficiency on hepatic redox status, 
we used male Cbs +/- mice and male Cbs +/+ from the same litter aged from 6 to 10 
months. As expected, heterozygous CBS-deficient mice displayed abnormal plasma 
Hcy levels compared to wild type mice (8.9±0.8 µM, n=10 vs. 3.9±0.3 µM, n=8; 
p<0.0001). 
 
HO-1 expression in the liver of CBS-deficient mice 
Induction of HO-1 expression is recognized as a marker of oxidative stress 
[45]. Therefore, the hepatic expression of HO-1 was analyzed to determine if the rise 
of Hcy induced by heterozygous CBS deficiency was sufficient to induce oxidative 
stress. We found an overexpression of HO-1 mRNA in the liver of Cbs +/- mice 
(100.0±6.0 % vs. 146.4±15.2 %; p=0.015, Fig. 2A). In agreement with increased 
levels of HO-1 mRNA, albeit the difference was not significant, HO-1 protein 
expression appeared to be increased (100.0±26.7 %, n=4 vs. 159.0±24.1 %, n=4; 
p<0.1, Fig. 2B). 
 
Effect of CBS deficiency on hepatic ROS production 
Even though NADPH oxidase activity was increased in liver of Cbs +/- mice 
(100.0±2.0 % vs. 109.6±2.5 %, p=0.04, Fig. 3A), there was no increase in O2˙- level. 
On the contrary, we observed a non significant decreased concentration of O2˙- 
(100.0±10.1 % vs. 81.1±5.6 %, p=0.28, Fig. 3B). The regulation of hepatic level of 
O2˙- could be due to an activation of SOD. However, we only observed a non 
significant increase in SOD activity (100.0±7.8 % vs. 113.1±7.1 %, p=0.48, Fig. 3C) 
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and surprisingly, we found a significant decrease in H2O2 level in liver of Cbs +/- mice 
compared to Cbs +/+ mice (100.0±5.2 % vs. 75.8±10.3 %, p=0.04, Fig. 3D). 
 
Effect of CBS deficiency on hepatic RNS production 
Reduced NO bioavailability is a key process in Hcy-induced vascular 
pathology but the implication of NO in liver diseases remains unclear [46]. We 
measured nitrites and nitrates levels as being representative of NO release. 
Measurement of nitrites alone did not gave detectable signal indicating that, in the 
liver, nitrates are the main NO derivatives. After nitrates reduction into nitrites we did 
not observed any significant difference between hepatic concentrations of Cbs +/- 
and Cbs +/+ mice (100.0±4.8 % vs. 104.0±8.5 %, p=0.80, Fig. 4A). The reaction of 
O2˙- with NO leads to the formation of ONOO-. As we have observed an increased 
production of O2˙- by NADPH oxidase but no accumulation of O2˙-, this could be due 
to an immediate reactivity of O2˙- with NO. However, there was no increase in ONOO- 
generation (100.0±12.6 % vs. 91.5±7.7 %, p=0.70, Fig. 4B) in liver of Cbs +/- mice 
compared to Cbs +/+ mice. 
 
Effect of CBS deficiency on hydrogen peroxide detoxification 
As we have observed a decreased H2O2 hepatic content, we investigated by 
which mechanism this ROS was detoxified. GPx is able to detoxify H2O2 by oxidizing 
GSH, the main cellular antioxidant compound. So we assayed GPx and GRed to 
determine if the decrease in H2O2 could be due to an activation of the GSH-
dependent detoxification cycle. Both GPx (100.0±4.3 % vs. 105.7±5.1 %, p=0.37, Fig. 
5A) and GRed (100.0±3.0 % vs. 103.9±4.2 %, p=0.50, Fig. 5B) activities remained 
unchanged in liver of Cbs +/- mice compared to Cbs +/+ mice. We also assayed 
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hepatic GST activity (100.0±6.8 % vs. 95.4±12.5 %, p=0.74, Fig. 5C) and found no 
variation. The liver is rich in CAT, a major enzyme involved in H2O2 detoxification. 
Then, we investigated if the decrease in hepatic H2O2 level could be due to CAT 
activation. Indeed, we found a 1.5-fold increase in CAT activity in liver of Cbs +/- 
mice compared to Cbs +/+ mice (100.0±3.8 % vs. 151.8±19.0 %, p=0.008, Fig. 5D). 
Then, we examined the expression of CAT to determine if the increase in activity was 
due to an overexpression. However, we did not found any variation of CAT mRNA 
expression between wild type mice and our hyperhomocysteinemic model (100.0±6.0 
% vs. 98.4±7.4 %, p=0.68), indicating that it is not a regulation of catalase activity at 
the molecular level.
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Discussion 
A moderate increase in Hcy level is considered as a risk factor for vascular 
diseases [5-8]. As in vitro studies demonstrated that Hcy leads to both increased 
ROS production and decreased antioxidant defenses [19,20,47], numerous studies 
focused on the vascular redox state of animal models. Hepatic metabolism also has a 
preponderant role on vascular function by regulating circulating cholesterol 
homeostasis [14-18]. However, only a limited number of studies characterized the 
hepatic redox state in case of hyperhomocysteinemia. Then we quantified hepatic 
levels of ROS and RNS and assayed activities of the main antioxidant enzymes in 
the liver of Cbs +/- mice. 
We decided to use a genetic model rather than a nutritional model to avoid 
Hcy-independent side effects induced by dietary modifications. Among nutrional 
approaches folate depletion and methionine enrichment are the most commonly 
used. Dietary models may be directly relevant to study general consequences of 
hyperhomocysteinemia since nutritional factors are the primary cause of Hcy 
accumulation in humans. However, as folates are important cofactors in 1-carbon 
metabolism, folate deficiency can lead to hypomethylation. Furthermore, Symons et 
al. [48], reported that folate depletion induced endothelial cell layer permeability 
independently of hyperhomocysteinemia. Similarly, Troen et al. [49] demonstrated 
that a high methionine diet induces vascular symptoms that are more strongly linked 
to the methionine load than to an Hcy accumulation in ApoE-deficient mice. On the 
other hand, homozygous CBS deficiency induces a decrease in GSH level [50] 
resulting from the complete blockade of the transsulfuration pathway. Hence, the 
redox state of Cbs -/- mice might be strongly influenced by GSH depletion. Therefore, 
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we used Cbs +/- mice, an intermediate model in which Hcy-independent 
perturbations are minimal, to study the mechanisms of hepatic Hcy toxicity. 
Concomitant with overexpression of HO-1, we found an increase in NADPH 
oxidase activity in the liver of Cbs +/- mice, which is in line with the results of Woo et 
al. in the liver of mice fed a high-methionine diet [26]. NADPH oxidase activation is 
the key step in the development of oxidative stress via an accumulation of O2˙-. 
However, there was no accumulation of O2˙- in the liver of Cbs +/- mice compared to 
Cbs +/+ mice. Moreover, we did not found any accumulation in plasma (data not 
shown) which is consistent with the results obtained by Dayal et al. in carotid artery of 
Cbs +/- mice [51]. Previous results showed that induction of HO-1 suppressed 
NADPH-oxidase-derived oxidative stress in hyperlipidemic apolipoprotein (E)-
deficient mice [52]. O2˙- also reacts rapidly with biological molecules. Then the 
modest increase in O2˙- production through NADPH oxidase activation might be 
quenched by an immediate reactivity of O2˙- with lipids, proteins, NO or to an 
increase in SOD activity. Previous studies associated increased oxidation of lipids 
and/or proteins with hyperhomocysteinemia due to whether CBS deficiency [53], 
methionine supplementation [27-28] or folate depletion [30].    
To assess the role of Hcy-induced hepatic physiopathology on NO 
bioavailability, we quantified RNS. As a measure of NO production we quantified 
nitrites after nitrates reduction in liver homogenates and found no difference between 
Cbs +/+ and Cbs +/- mice. Once produced by NO synthase, NO can react with O2˙- to 
form ONOO- which can notably damage proteins and DNA. We then quantified 
ONOO- in the liver of Cbs +/- mice but found no difference compared to Cbs +/+ 
mice. Moreover, as it has been described in folate deficiency [30] and methionine 
supplementation [28] there was no activation of SOD in the liver of Cbs +/- mice. The 
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dismutation of O2˙- by SOD results in the formation of H2O2, a less cytotoxic ROS but 
which can lead to the formation of the highly reactive hydroxyl radical. Against all 
expectations, we found a 25% decrease in H2O2 hepatic concentration in Cbs +/- 
mice compared to their Cbs +/+ littermates. We then investigated which antioxidant 
process could account for such a decrease. 
Activities of GPx, GRed and GST in the liver of Cbs +/- mice were similar to 
those observed in Cbs +/+ mice. These results indicate that GSH-dependent 
detoxification of H2O2 or oxidized lipids is not activated by Hcy. This finding is in 
agreement with the independence of hepatic GSH concentration and heterozygous 
CBS deficiency previously reported by Likogianni et al. [54]. Nevertheless, this is 
discrepant with previous results obtained with murine models of 
hyperhomocysteinemia. In heterozygous CBS-deficient mice, Weiss et al. reported a 
14 % decrease in GPx-1 activity [31]. This difference might arise from the fact that 
there is a 6.5-fold factor between the folate contents of our diets. In the cell, GPx 
contribution to H2O2 detoxification is much less than that of CAT [55]. Then, we 
analyzed CAT activity and found a 1.5-fold increase in the liver of Cbs +/- mice 
compared to Cbs +/+ mice. This increase could explain the decrease in H2O2 hepatic 
content in Cbs +/- mice. We found that the increase in CAT activity was not due to an 
overexpression. It is known that CAT activity is regulated via modulation of 
phosphorylations [56]. In this sense, we showed the activation of protein kinase A 
(PKA) signalling pathways in an ex vivo model of hippocampal slices incubated with 
Hcy [57]. Moreover, Woo et al. also demonstrated in hepatocytes the involvement of 
PKA signalling pathway in hyperhomocysteinemia [58]. Thus, the activation of PKA 
by Hcy in hepatocytes could explain the observed increase in CAT activity. Previous 
studies with dietary approaches observed either a decrease [26,27] or no difference 
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[28-30] of CAT activity in the liver of Cbs +/- mice compared to Cbs +/+ mice. Such 
heterogeneity could arise from the fact that different animal models have been used. 
For instance, a limitation to some studies is that methionine-enriched diet increases 
GSH levels in wild-type mice which could interfere with Hcy-induced oxidative stress 
[54]. 
 
Our results showed that there was no accumulation of ROS and RNS in the liver of 
CBS-deficient mice despite an activation of NADPH oxidase. This ability of the liver to 
maintain its redox balance seems to be due to a significant increase in CAT activity. 
In aorta of the same model of hyperhomocysteinemia evoked by CBS deficiency, 
Eberhardt et al. [11] reported an increased staining for 3-nitrotyrosine, a marker of 
peroxynitrite formation, on the endothelial surface. Furthermore, they observed a 
trend to enhanced lipid peroxidation in serum but not in the liver of CBS-deficient 
mice. Taken together, their and our findings suggest that Hcy is more deleterious for 
the vessels than for the liver. This hepatic strength might be due to better antioxidant 
defenses, as CAT activity is about 10-fold higher in the liver than in the aorta [59,60]. 
Furthermore, we previously demonstrated that Hcy is intracellular in hepatocytes 
whereas it is not detected in vascular endothelial and vascular smooth muscle cells 
[61]. Hence, Hcy toxicity could implicate different pathways depending on whether 
Hcy is intracellular or extracellular. 
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Table 1 
Primer sequences for real-time quantitative reverse transcription-polymerase chain 
reaction. 
Gene Left primer Right primer 
 
Cat 
 
CCTCCTCGTTCAGGATGTGGTT CGAGGGTCACGAACTGTGTCAG 
 
Ho-1 
 
GCAGGTGATGCTGACAGAGGAA GGGGGCCAGTATTGCATTTACA 
 
Sod-1 
 
TGGGGACAATACACAAGGCTGT TTTCCACCTTTGCCCAAGTCA 
All primers are listed 5' to 3'. Cat: catalase, Ho-1: heme oxygenase-1, Sod-1: superoxide dismutase-1. 
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Figure legends 
Fig. 1. Integrated pathways for homocysteine and glutathione synthesis from 
methionine. DHF, dihydrofolate; DHFR, dihydrofolate reductase; THF, 
tetrahydrofolate reductase; STHM, serine transhydroxymethylase; CH2THF, 5,10-
methylene tetrahydrofolate; MTHFR, 5,10-methylene tetrahydrofolate reductase; 
CH3THF, 5-methyl tetrahydrofolate; MS, methionine synthase; BHMT, betaine 
homocysteine methyl transferase; DMG, N,N-dimethyl glycine; MAT, methionine 
adenosyl transferase; SAM, S-adenosyl methionine; SAH, S-adenosyl homocysteine; 
SAHH, S-adenosyl homocysteine hydrolase; CBS, cystathionine beta synthase; CGL, 
cystathionine gamma lyase; γGCS, γ-glutamyl cysteine synthase; GS, glutathione 
synthetase; GPx, glutathione peroxidase; GSSG, oxidized glutathione; NADPH, 
reduced nicotinamide adenine dinucleotide phosphate; G6PD, glucose 6-phosphate 
dehydrogenase; NADP, oxidized nicotinamide adenine dinucleotide phosphate; 
GRed, glutathione reductase. 
 
Fig. 2. Effect of CBS genotype on HO-1 expression. HO-1 mRNA levels (A) were 
quantified by real-time quantitative reverse transcription-polymerase chain reaction. 
Expression levels are presented as mean percentages ± SEM of mean values of n 
(number of mice) Cbs +/+ mice. Effect of CBS genotype on HO-1 protein levels has 
been determined by Western blotting (B). The presented blot specific for HO-1 and β-
actin, as a loading control, is representative of 3 experiments with 4 mice in each 
group. * : p<0.05. 
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Fig. 3. Production and concentration of O2˙- and H2O2 in the liver of Cbs +/+ and Cbs 
+/- mice. Activities and concentrations are presented as mean percentages ± SEM of 
mean values of n (number of mice) Cbs +/+ mice. * : p<0.05. 
 
Fig. 4. Effect of CBS deficiency on RNS hepatic content. Concentrations are 
presented as mean percentages ± SEM of mean concentration of n (number of mice) 
Cbs +/+ mice. Nitrites were quantified after nitrates reduction. 
 
Fig. 5. Activities of hydrogen peroxide detoxification enzymes in the liver of Cbs +/+ 
and Cbs +/- mice. GPx, GRed, GST and CAT activities are presented as mean 
percentages ± SEM of mean activities of n (number of mice) Cbs +/+ mice. * : 
p<0.05. 
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Fig 5 
 
